





Pseudomyxoma Peritonei (PMP), also called jelly-belly, literally means "false mucinous tumour of the peritoneum." Pseudomyxoma peritonei is a rare clinical syndrome caused by mucin‑producing tumours, most commonly originating from the appendix, and can range from low‑grade to high‑grade malignancy.
PMP occurs when mucin-producing cancer cells spread inside the peritoneum (the smooth tissue lining of the abdominal organs). The symptoms of this disease tend to be mild, like bloating or indigestion. The unusual signs make its detection very difficult.
But there is hope for the people who are diagnosed with PMP. Keep reading to learn the causes, symptoms, diagnosis, and treatment options for Pseudomyxoma peritonei.
Pseudomyxoma Peritonei Cancer is a very rare case of cancer that impacts your peritoneal cavity (your abdomen and pelvis). It fills your abdomen and pelvis with cancer cells that generate mucin. Mucin is a jelly-like substance that’s one of the mucus component.
The name of this medical condition means ‘false mucinous tumour of the peritoneum’. Doctors call this disease a 'false tumour' primarily because its initial growth is dominated by the accumulation of large amounts of jelly-like mucin (mucinous ascites) rather than a solid, single mass. However, the cancer cells themselves do form neoplastic tissue, known as peritoneal implants, which proliferate and spread throughout the abdomen. In contrast, the disease initiates as a cancerous polyp in your appendix.
When the polyp breaks by your appendix. It triggers a flood of mucin-producing cancer cells that, with the time, impact your digestive system. That abundance of jelly-like mucin is why some people known PMP “Jelly belly”.
Symptoms of pseudomyxoma peritonei tend to be mild and may feel like common issues such as constipation or indigestion. In some cases, doctor identifies PMP early on while performing your yearly medical examination or while checking for another medical condition. In case you are like most people, however, you will find out you have PMP because your belly issues do not go away or get worse.
The Psemyxoma Peritonia begins in the appendix. A small perforation forms in the appendix due to a polyp or tumour formed on its surface. The polyp ruptures, bursting the appendix along with it. Mucin-producing cancer cells flood the abdominal and pelvic cavities.
Wherever the cells reach, they continue to grow. The most affected areas are the fatty membranes on the intestines, below the muscle that separates the chest from the abdomen, and the pelvis. In women, there can be an excessive growth of cancerous cells in both ovaries.
The mucin is a jelly-like substance, hence the name Jelly-Belly. As is the case of most cancers, no one knows why the tumours form.
The biological behaviour of PMP varies; low‑grade disease is typically slow‑growing, while high‑grade PMP can be aggressive. Early PMP is typically asymptomatic. Advanced cases may cause progressive abdominal distension (jelly belly), bowel obstruction, or ovarian involvement in women. The typical signs include:
None of these signs are atypical. These are subtle symptoms that get overlooked as mild gastric issues and PMP detection get delayed.
A person is diagnosed with PMP when their symptoms have become severe. The doctor orders the following tests:
The chief treatment for PMP is surgery. A peritonectomy (a cytoreductive surgery) will help remove the mucin and the mucinous cysts throughout the abdomen. The doctors prescribe either chemotherapy, radiation, or both after surgery.
Pseudomyxoma peritonei can recur even after surgery. But with care and proper treatment, people go on to live long, fulfilling lives.
While there is no way to prevent PMP, paying attention to any abdominal symptoms will help in early detection. Having a history of ovarian cancer puts those women at a greater risk.
There is always an ultimate chance that surgery to remove organs will result into complications such as haemorrhage, infection or anastomotic leak. Around 1–2% of people die after the definitive PMP treatment, which is highly specialized Cytoreductive Surgery (CRS) combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). This rate is an estimate for this complex, high-risk procedure performed in specialized centres, where major operative complications can occur in 20–30% of patients.
Long‑term disease control and survival are achievable in many patients, particularly those with low‑grade disease and complete cytoreduction, but outcomes vary widely. With constant monitoring, early diagnosis, and family support, a healthy and improved life is possible.
Reader information: This article is intended for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Pseudomyxoma peritonei is a rare and complex condition, and individual cases may vary significantly in presentation, severity, and outcomes. Information provided here should not be used as a substitute for professional medical consultation. Readers are advised to seek guidance from a qualified healthcare professional for diagnosis, treatment decisions, and personalized medical care.
Also Read:
→ Hyperferritinemia-Cataract Syndrome
→ Different Types of LAD Syndrome
→ How is Mowat-Wilson Syndrome Diagnosed